Publications by authors named "Jason Vittitow"

Claim this Profile
E
Effect of increasing chain length on inhibition of evaporation by perfluoro compounds in an in vitro gravimetric assay.
Megan E Cavet, Jason L Vittitow, Douglas Borchman

Exp Eye Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study.
Jason Bacharach, Shane R Kannarr, Anthony Verachtert, Preeya K Gupta, Moataz Razeen, Jason L Vittitow

Ophthalmol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro and In Vivo Visualization of Perfluorohexyloctane, an Eye Drop for Dry Eye Disease, Using Infrared Emissivity.
Thomas James Millar, Jason Vittitow, Megan Cavet, Simra Ahmed, Douglas Borchman

Cornea· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials.
Ahmad M Fahmy, Jennifer S Harthan, David G Evans, Jack V Greiner, Joseph Tauber, Jason L Vittitow

Front Ophthalmol (Lausanne)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study.
Eugene E Protzko, Bruce A Segal, Michael S Korenfeld, Sonja Krösser, Jason L Vittitow

Cornea· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study.
John D Sheppard, Fred Kurata, Alice T Epitropoulos, Sonja Krösser, Jason L Vittitow

Am J Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
Joseph Tauber, Gregg J Berdy, David L Wirta, Sonja Krösser, Jason L Vittitow

Ophthalmology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease.
Jason Vittitow, Robert Kissling, Heleen DeCory, Douglas Borchman

Curr Ther Res Clin Exp· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease.
Neal Stolowich, Jason Vittitow, Robert Kissling, Douglas Borchman

Curr Ther Res Clin Exp· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.
Peter Couroux, Alexandre Brkovic, Jason L Vittitow, Robert J Israel, Chinna Pamidi

Clin Transl Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
Jason L Vittitow, Jon I Williams

J Cataract Refract Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.
Raymond Fong, Megan E Cavet, Heleen H DeCory, Jason L Vittitow

Clin Ophthalmol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.
Stacey L Ackerman, Gail L Torkildsen, Eugene McLaurin, Jason L Vittitow

Clin Exp Optom· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
Raymond Fong, Bruce E Silverstein, James H Peace, Jon I Williams, Jason L Vittitow

J Cataract Refract Surg· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings.
Robert N Weinreb, Jeffrey M Liebmann, Keith R Martin, Paul L Kaufman, Jason L Vittitow

J Glaucoma· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
John H K Liu, John R Slight, Jason L Vittitow, Baldo Scassellati Sforzolini, Robert N Weinreb

Am J Ophthalmol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.
Kazuhide Kawase, Jason L Vittitow, Robert N Weinreb, Makoto Araie,

Adv Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study.
Felipe A Medeiros, Keith R Martin, James Peace, Baldo Scassellati Sforzolini, Jason L Vittitow

Am J Ophthalmol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Robert N Weinreb, Baldo Scassellati Sforzolini, Jason Vittitow, Jeffrey Liebmann

Ophthalmology· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.
Makoto Araie, Baldo Scassellati Sforzolini, Jason Vittitow, Robert N Weinreb

Adv Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh

Br J Ophthalmol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma.
Carol A Rasmussen, Paul L Kaufman, Robert Ritch, Reza Haque, R Kim Brazzell, Jason L Vittitow

Transl Vis Sci Technol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide (NO): an emerging target for the treatment of glaucoma.
Megan E Cavet, Jason L Vittitow, Francesco Impagnatiello, Ennio Ongini, Elena Bastia

Invest Ophthalmol Vis Sci· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
Esen Karamursel Akpek, Jason Vittitow, Rozemarijn S Verhoeven, Kurt Brubaker, Thierry Amar

J Ocul Pharmacol Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells.
Inna Grosheva, Jason L Vittitow, Polina Goichberg, B'Ann True Gabelt, Paul L Kaufman

Exp Eye Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis